Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 376 AL 390

NIA-funded Alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia

Edland SD, Emond JA, Aisen PS, Petersen RC.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):159-64. doi: 10.1097/WAD.0b013e3181c9983f.

A single ascending dose study of bapineuzumab in patients with Alzheimer disease

Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, Grundman M.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):198-203. doi: 10.1097/WAD.0b013e3181c53b00.

Botulinum toxin as a solution in voluntary hip dislocation after modular unipolar hemiarthroplasty

Eren A, Ozkan K, Unay K, Sahin A, Poyanli O.

Orthopedics. 2010 May 12;33(5). doi: 10.3928/01477447-20100329-25.

Macrophages in Alzheimer's disease: the blood-borne identity

Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T.

J Neural Transm (Vienna). 2010 Aug;117(8):961-70. doi: 10.1007/s00702-010-0422-7. Epub 2010 Jun 2.

APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics

Hussain I.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):395-402. doi: 10.2174/187152710791556087.

The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease

Wilcock DM.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):386-94. doi: 10.2174/187152710791556168.

Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)

Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B; PLASA Group.

BMJ. 2010 Jun 3;340:c2466. doi: 10.1136/bmj.c2466.

Care plans for people with Alzheimer's disease

Schneider LS.

BMJ. 2010 Jun 3;340:c2626. doi: 10.1136/bmj.c2626.

Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia

Wang Y, Huang LQ, Tang XC, Zhang HY.

Acta Pharmacol Sin. 2010 Jun;31(6):649-64. doi: 10.1038/aps.2010.46.

Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer's disease

Kubová Z, Kremlácek J, Valis M, Langrová J, Szanyi J, Vít F, Kuba M.

Doc Ophthalmol. 2010 Aug;121(1):37-49. doi: 10.1007/s10633-010-9230-5. Epub 2010 Jun 4.

Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease

Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, Nicoll JA.

Acta Neuropathol. 2010 Jul;120(1):13-20. doi: 10.1007/s00401-010-0705-y. Epub 2010 Jun 9.

Tacrine-NO donor and tacrine-ferulic acid hybrid molecules as new anti-Alzheimer agents: hepatotoxicity and influence on the cytochrome P450 system in comparison to tacrine

Lupp A, Appenroth D, Fang L, Decker M, Lehmann J, Fleck C.

Arzneimittelforschung. 2010;60(5):229-37. doi: 10.1055/s-0031-1296278.

Alzheimer disease and HIV: a tangled story

Brew BJ, Cysique LA.

Neurology. 2010 Jul 13;75(2):105-6. doi: 10.1212/WNL.0b013e3181e7b6a4. Epub 2010 Jun 9.

Meeting report: the 7th Leonard Berg Symposium, part 1

Strobel G.

J Alzheimers Dis. 2010;20(3):943-8. doi: 10.3233/JAD-2010-100013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias